USANA Health Sciences Inc (USNA)
Working capital turnover
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 856,402 | 864,228 | 877,532 | 902,933 | 923,927 | 930,694 | 950,819 | 977,178 | 1,001,860 | 1,041,382 | 1,082,496 | 1,155,009 | 1,190,168 | 1,235,586 | 1,258,823 | 1,180,028 | 1,137,751 | 1,095,421 | 1,057,506 | 1,054,531 |
| Total current assets | US$ in thousands | 279,187 | 451,191 | 419,081 | 421,070 | 417,746 | 390,460 | 387,646 | 395,878 | 384,382 | 341,154 | 342,004 | 363,785 | 365,117 | 368,425 | 381,506 | 373,180 | 425,286 | 386,032 | 324,949 | 286,763 |
| Total current liabilities | US$ in thousands | 139,625 | 114,779 | 103,896 | 112,631 | 118,845 | 112,559 | 113,839 | 130,222 | 143,833 | 125,846 | 133,594 | 157,967 | 160,790 | 157,964 | 153,000 | 151,452 | 168,073 | 160,863 | 139,717 | 124,504 |
| Working capital turnover | 6.14 | 2.57 | 2.78 | 2.93 | 3.09 | 3.35 | 3.47 | 3.68 | 4.16 | 4.84 | 5.19 | 5.61 | 5.82 | 5.87 | 5.51 | 5.32 | 4.42 | 4.86 | 5.71 | 6.50 |
December 31, 2024 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $856,402K ÷ ($279,187K – $139,625K)
= 6.14
The working capital turnover ratio for USANA Health Sciences Inc has fluctuated over the given period, starting at 6.50 on March 31, 2020 and reaching its peak at 6.14 on December 31, 2024, before starting to decline. The ratio indicates how efficiently the company is utilizing its working capital to generate sales revenue.
A higher working capital turnover ratio generally suggests efficient management of working capital, as the company is able to generate more revenue with less investment in working capital. Conversely, a decreasing trend in the ratio may indicate that the company's sales are not increasing proportionally to its working capital.
Overall, the working capital turnover for USANA Health Sciences Inc has shown fluctuations but remained relatively strong, staying above 4 for the majority of the period, with a peak of 6.14. Monitoring this ratio over time can provide insights into the company's operational efficiency and financial performance.